Changes in serum YKL-40 levels in patients with rheumatoid arthritis during treatment with anti-TNF-alfa therapy.

被引：0
|
作者：
Johansen, JS
Hetland, ML
Jacobsen, S
Price, PA
Skjodt, H
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Dept Rheumatol, DK-2650 Hvidovre, Denmark
[2] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [1] Changes in plasma IL-6, plasma VEGF and serum YKL-40 levels in patients with rheumatoid arthritis during treatment with anti-TNF-α therapy.
    Knudsen, LS
    Ostergaard, M
    Baslund, B
    Petersen, J
    Ejbjerg, B
    Szkudlarek, M
    Johansen, JS
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S378 - S378
  • [2] Changes in serum YKL40 levels in patients with rheumatoid arthritis and Ankylosing spondylitis during treatment with anti-TNF-alpha therapy.
    Johansen, JS
    Hetland, ML
    Ostergaard, M
    Majgaard, O
    Skjodt, H
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S545 - S545
  • [3] Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy
    Hu, Wenlu
    Ding, Yanxia
    Guan, Kelei
    Zhang, Panpan
    Su, Jingbo
    Zhang, Chunyi
    Li, Wei
    Lian, Chaofeng
    Yang, Qihua
    Liu, Shengyun
    Li, Tianfang
    CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 1845 - 1853
  • [4] Serum YKL-40 levels in patients with rheumatoid arthritis.
    Johansen, JS
    Hansen, M
    Klarlund, M
    Price, PA
    Volck, B
    Lorenzen, I
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S278 - S278
  • [5] Serum YKL-40, a chondrocyte protein, is reduced by infliximab (anti-TNF) therapy in patients with rheumatoid arthritis
    Charles, PJ
    Maini, RN
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S236 - S236
  • [6] Use of anti-TNF-alfa in rheumatoid arthritis
    Del Pilar Vicente-Sanchez, Maria
    Aurora Apezteguia-Fernandez, Carolina
    Ibanez-Heras, Nuria
    Garrido-Peno, Noelia
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 735 - 735
  • [7] Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
    Jafari-Nakhjavani, Mohammad Reza
    Ghorbanihaghjo, Amir
    Bagherzadeh-Nobari, Babak
    Malek-Mahdavi, Aida
    Rashtchizadeh, Nadereh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2019, 10 (01) : 92 - 97
  • [8] Changes in serum YKL-40 in patients with rheumatoid arthritis treated with leflunomide.
    Volck, B
    Johansen, JS
    Loew-Friedrich, I
    Price, PA
    Oed, C
    Rosenburg, R
    Lorenzen, I
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S83 - S83
  • [9] Changes in plasma IL-6, plasma VEGF and serum YKL-40 levels in patients with rheumatoid arthritis during treatment with etanercept
    Knudsen, LS
    Hetland, ML
    Johansen, JS
    Skjodt, H
    Peters, ND
    Colic, A
    Grau, K
    Nielsen, HJ
    Ostergaard, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 195 - 195
  • [10] Serum YKL-40 in patients with early rheumatoid arthritis.
    Johansen, JS
    Sharif, M
    Price, PA
    Kirwan, JR
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S129 - S129
12345